Oligonucleotides: Global Markets to 2026

Report Scope: This report covers the worldwide market for oligonucleotide synthesis, which consists of four main product types: oligonucleotide drugs, synthesized oligos, equipment and reagents, and services.

New York, Aug. 30, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Oligonucleotides: Global Markets to 2026” – https://www.reportlinker.com/p06131004/?utm_source=GNW
Based on application, the market for oligonucleotide synthesis is divided into research and diagnostics and therapeutics.

By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW).The report includes detailed analyses of the major countries in these regions.

For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026.

The report also covers approved drugs, the oligonucleotide synthesis process, innovative research, opportunities within the market and profiles of leading companies in the oligonucleotide synthesis industry.

Report Includes:
– 22 data tables and 20 additional tables
– An overview of the global market for oligonucleotides
– Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
– Evaluation of current market trends, and technological advancements within the industry and market share analysis of oligonucleotides by type, application, and region
– Information on the classifications and applications of oligonucleotides and detailed description of DNA oligos and RNA oligos synthesis
– Details of solid phase chemical synthesis and alternative forms of oligonucleotide synthesis processes and insights into government regulations for oligonucleotide-based drugs
– Information on CRISPR-Cas diagnosis and therapeutic tools for SARS-CoV-2 infection, and discussion on ASO as a COVID-19 therapeutic
– A look at the new product developments, clinical trials, patents, mergers and acquisitions and collaborations or partnership of the industry
– Company profiles of major players of the industry, including Agilent Technologies , Eurofins Scientific, Biolegio, Merck KGaA , Integrated DNA Technologies and Thermo Fisher Scientific

Summary:
The term oligonucleotide is derived from the Greek word oligo, which means small or few. The base length of the oligos is usually identified as “mer,” which means “part” in the Greek language.

Oligonucleotides are short DNA/RNA strands.These can be made based on client requirements by solid phase chemical synthesis.

They are made up of 13 to 25 bases to hybridize to complementary sequence.

These oligos are primarily used in polymerase chain reaction (PCR) as a probe, but are also used in DNA based microarray techniques, Southern blot assay, FISH (Fluorescent In Situ Hybridization), and ASO analysis.

Along with its diagnostics and research uses, oligonucleotides are also being used…